BBA
FOLD

Baker Bros. Advisors’s Amicus Therapeutics FOLD Stock Holding History

Baker Bros. Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-481,697
Closed -$4.01M – 132
2014
Q4 		$4.01M Hold
481,697
– – 0.04% 77
2014
Q3 		$2.87M Hold
481,697
– – 0.04% 80
2014
Q2 		$1.61M Hold
481,697
– – 0.02% 93
2014
Q1 		$997K Sell
481,697
-33,375
-6% -$83.4K 0.01% 98
2013
Q4 		$1.21M Hold
515,072
– – 0.02% 86
2013
Q3 		$1.2M Hold
515,072
– – 0.02% 76
2013
Q2 		$1.2M Buy
+515,072
New +$1.58M 0.02% 66

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Bros. Advisors's FOLD Position: Q1 2015 in Review

Baker Bros. Advisors sold out of Amicus Therapeutics (FOLD) in Q1 2015, closing a stake of 481,697 shares — an estimated $4.01M sold.

Baker Bros. Advisors first reported a position in FOLD in Q2 2013 and held it in 7 quarters. The position peaked at $4.01M in Q4 2014. 125 funds tracked by Wall St. Rank hold FOLD as of Q1 2015.

  • Baker Bros. Advisors reported no remaining Amicus Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Baker Bros. Advisors sold 481,697 Amicus Therapeutics shares in Q1 2015, an estimated $4.01M.
  • Baker Bros. Advisors first reported a position in Amicus Therapeutics in Q2 2013 and held it in 7 quarters.
  • Baker Bros. Advisors's Amicus Therapeutics position peaked at $4.01M in Q4 2014.
  • 125 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2015.

Based on Baker Bros. Advisors's 13F filing for Q1 2015, filed 15 May 2015.